Curis
CRIS
#10257
Rank
โ‚ฌ19.08 M
Marketcap
0,48ย โ‚ฌ
Share price
3.17%
Change (1 day)
-57.38%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -โ‚ฌ29.24 Million

According to Curis's latest financial reports the company's current earnings are โ‚ฌ11.65 Million. In 2024 the company made an earning of -โ‚ฌ37.13 Million, an increase over its 2023 earnings that were of -โ‚ฌ39.4 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ29.24 Million-21.26%
2024 -โ‚ฌ37.13 Million-5.77%
2023 -โ‚ฌ39.4 Million-13.1%
2022 -โ‚ฌ45.34 Million27.52%
2021 -โ‚ฌ35.56 Million65.09%
2020 -โ‚ฌ21.54 Million-9.1%
2019 -โ‚ฌ23.7 Million-4.73%
2018 -โ‚ฌ24.87 Million-41.95%
2017 -โ‚ฌ42.84 Million-14.37%
2016 -โ‚ฌ50.03 Million3.55%
2015 -โ‚ฌ48.31 Million271.52%
2014 -โ‚ฌ13.01 Million76.64%
2013 -โ‚ฌ7.37 Million
2011 -โ‚ฌ6.26 Million27.76%
2010 -โ‚ฌ4.9 Million-43.87%
2009 -โ‚ฌ8.72 Million-23.44%
2008 -โ‚ฌ11.39 Million56.66%
2007 -โ‚ฌ7.27 Million-16.71%
2006 -โ‚ฌ8.73 Million-36.92%
2005 -โ‚ฌ13.84 Million156.25%
2004 -โ‚ฌ5.4 Million-37.24%
2003 -โ‚ฌ8.61 Million-93.34%
2002 -โ‚ฌ0.13 Billion86.79%
2001 -โ‚ฌ69.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ8.84 B-31,404.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ8.09 B-28,750.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚ฌ53.71 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚ฌ0.81 B-2,990.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚ฌ0.25 Billion 782.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚ฌ21.5 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.14 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA